methylprednisolone has been researched along with Acquired Language Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dahl-Cruz, F; Díaz-Marín, C; Elvira-Soler, E; López-Hernández, N; Serrano-Serrano, B | 1 |
Arias, M; Arias-Rivas, S; Fernandez-Pajarin, G; Lopez-Gonzalez, FJ; Requena-Caballero, I; Rodriguez-Osorio, X | 1 |
Boss, HM; Braun, KP; de Jager, W; de Vries, EE; Jansen, FE; van den Munckhof, B; van Royen-Kerkhof, A; Willemsen, MA | 1 |
1 review(s) available for methylprednisolone and Acquired Language Disorders
Article | Year |
---|---|
[Recurrence of encephalitis after 25 years due to anti-NMDA receptor antibodies].
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Autoantibodies; Autoantigens; Critical Care; Drug Therapy, Combination; Fluoxetine; Hallucinations; Humans; Immunoglobulins, Intravenous; Language Disorders; Magnetic Resonance Imaging; Male; Mental Disorders; Methylprednisolone; Middle Aged; Paresis; Receptors, N-Methyl-D-Aspartate; Recurrence; Respiration Disorders; Seizures; Time Factors | 2014 |
2 other study(ies) available for methylprednisolone and Acquired Language Disorders
Article | Year |
---|---|
[Multifocal encephalitis as a neurological manifestation of COVID-19 infection].
Topics: Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Infectious Encephalitis; Language Disorders; Magnetic Resonance Imaging; Male; Methylprednisolone; Nasopharynx; Neuroimaging; Pandemics; Pneumonia, Viral; Psychomotor Agitation; SARS-CoV-2; Tremor | 2020 |
Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome.
Topics: Adolescent; Case-Control Studies; Chemokine CCL2; Chemokine CCL3; Child; Child, Preschool; Cognition Disorders; Cytokines; Electroencephalography; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Inflammation; Interleukin-10; Interleukin-1alpha; Interleukin-6; Interleukin-8; Intramolecular Oxidoreductases; Language Disorders; Macrophage Migration-Inhibitory Factors; Male; Methylprednisolone; Neuropsychological Tests; Prednisolone; Sleep Wake Disorders; Status Epilepticus; Syndrome; Treatment Outcome | 2016 |